JAMES R. KASINGER

CIK 1708172 · General Counsel and Secretary · last filed 2026-06-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.70M

Companies

2

Total Filings

39

Lifetime Open-Market Net

-$7.71M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRSP General Counsel and Secretary 94,308 $49.80 $4.70M -$7.71M 38 2026-06-02
CRISPR Therapeutics AG (PZRX) Delisted General Counsel and Secretary $0 1 2017-06-02

Recent Filings · Page 3 of 4

39 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-10-12 CRSP Grant (A) $0 EDGAR
2022-08-18 CRSP Grant (A) $0 EDGAR
2022-03-14 CRSP Mixed +2,724 -$146.1K EDGAR
2022-02-22 CRSP Grant (A) $0 EDGAR
2021-12-07 CRSP Mixed +7,030 -$436.0K EDGAR
2021-12-03 CRSP Exer (M) +7,342 $100.0K EDGAR
2021-10-18 CRSP Grant (A) $0 EDGAR
2021-09-14 CRSP Mixed +5,259 -$558.8K EDGAR
2021-03-12 CRSP Mixed +1,480 -$168.0K EDGAR
2021-01-20 CRSP Mixed -$4.22M EDGAR
Showing 2130 of 39
Page 3 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.